Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by RickyBobbyTOon Jul 12, 2022 12:03pm
113 Views
Post# 34818193

RE:RE:RE:RE:RE:RE:RE:RE:RE:A must watch PMX presentation by Dr. Kellum

RE:RE:RE:RE:RE:RE:RE:RE:RE:A must watch PMX presentation by Dr. Kellum

any amount of shares purchased today will probably be shorted by hedge funds who will cover with financing paper. You literally need 20 million dollars plus worth of purchasing for the price to really move. And even then it's unlikely the company wouldn't just take 20 m financing to pay salaries. What a bunch of amateurs. 


Accountprince wrote: The share value is way higher than the price it's been held at for over 2 years now.  With risk for both DIMI and PMX I felt the range was $8 to $10 a share at a 50% risk discount.  But as MM recently pointed out to me the risk has dramatically fallen so perhaps $15 to $20 a share is now closer to value.

But as we can see in the market right now there's special interests that want to keep it at much lower levels.  Never seen manipulation so blatant...

 

<< Previous
Bullboard Posts
Next >>